These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33862253)

  • 1. Constitutive nitric oxide synthase-like enzyme in two species involved in cutaneous and mucocutaneous leishmaniasis.
    Furtado RR; Soares DC; Prado AF; Farias LHS; Da Silva BJM; Rodrigues APD; Silva EO
    Parasitol Int; 2021 Aug; 83():102347. PubMed ID: 33862253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the nitric oxide production by Leishmania sp.
    Genestra M; de Souza WJ; Cysne-Finkelstein L; Leon LL
    Med Microbiol Immunol; 2003 Nov; 192(4):217-23. PubMed ID: 12827512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.
    Giudice A; Camada I; Leopoldo PT; Pereira JM; Riley LW; Wilson ME; Ho JL; de Jesus AR; Carvalho EM; Almeida RP
    BMC Infect Dis; 2007 Feb; 7():7. PubMed ID: 17316450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide biosynthesis by Leishmania amazonensis promastigotes containing a high percentage of metacyclic forms.
    Genestra M; Souza WJ; Guedes-Silva D; Machado GM; Cysne-Finkelstein L; Bezerra RJ; Monteiro F; Leon LL
    Arch Microbiol; 2006 Jun; 185(5):348-54. PubMed ID: 16575586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania braziliensis prostaglandin F
    Alves-Ferreira EVC; Ferreira TR; Walrad P; Kaye PM; Cruz AK
    Parasit Vectors; 2020 Jan; 13(1):9. PubMed ID: 31915065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis.
    Ângelo de Souza L; Silva E Bastos M; de Melo Agripino J; Souza Onofre T; Apaza Calla LF; Heimburg T; Ghazy E; Bayer T; Ferraz da Silva VH; Dutra Ribeiro P; Licursi de Oliveira L; Costa Bressan G; de Almeida Lamêgo MR; Silva-Júnior A; de Souza Vasconcellos R; Suarez-Fontes AM; Almeida-Silva J; Vannier-Santos MA; Pierce R; Sippl W; Lopes Rangel Fietto J
    Biochem Pharmacol; 2020 Oct; 180():114191. PubMed ID: 32777278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis.
    Carneiro PP; Conceição J; Macedo M; Magalhães V; Carvalho EM; Bacellar O
    PLoS One; 2016; 11(2):e0148084. PubMed ID: 26840253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
    Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
    Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amidine derivatives and Leishmania amazonensis: an evaluation of the effect of nitric oxide (NO) production on the parasite-macrophage interaction.
    Temporal RM; Cysne-Finkelstein L; Echevarria A; Silva-Gonçalves AJ; Leon LL; Genestra MS
    J Enzyme Inhib Med Chem; 2005 Feb; 20(1):13-8. PubMed ID: 15895679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promastigote parasites cultured from the lesions of patients with mucosal leishmaniasis are more resistant to oxidative stress than promastigotes from a cutaneous lesion.
    Ávila LR; Gomes CM; Oliveira PG; Gomes RS; Vinaud MC; Dorta ML; Uliana SRB; Ribeiro-Dias F; Oliveira MAP
    Free Radic Biol Med; 2018 Dec; 129():35-45. PubMed ID: 30196081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein map of the protozoan parasite Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum during growth phase transition and temperature stress.
    Mule SN; Saad JS; Sauter IP; Fernandes LR; de Oliveira GS; Quina D; Tano FT; Brandt-Almeida D; Padrón G; Stolf BS; Larsen MR; Cortez M; Palmisano G
    J Proteomics; 2024 Mar; 295():105088. PubMed ID: 38237666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].
    Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR
    Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase expression modulates nitric oxide production in Leishmania (Leishmania) amazonensis.
    Acuña SM; Aoki JI; Laranjeira-Silva MF; Zampieri RA; Fernandes JCR; Muxel SM; Floeter-Winter LM
    PLoS One; 2017; 12(11):e0187186. PubMed ID: 29135983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test.
    Garcez LM; Silveira FT; el Harith A; Lainson R; Shaw JJ
    Acta Trop; 1997 Oct; 68(1):65-76. PubMed ID: 9352003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.